The Phase I trial conducted concurrently in China and the United States, was designed to evaluate the safety, tolerability, pharmacokinetics, pharmacodynamics and preliminary anti-tumor activity ...
11d
The Brighterside of News on MSNRevolutionary new cancer treatment destroys tumors in less than 6 daysResearchers from Rice University and Baylor College of Medicine have developed a new treatment that eliminates advanced-stage ...
At present, education is not considered a high-risk industry for malignant mesothelioma. Off Education employees do not fit the typical patient profile of mesothelioma and asbestos exposure. Despite ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results